A phase II study of Avelumab + stereotactic ablative body radiosurgery (SABR) for metastatic castration-resistant prostate cancer (mCRPC)

Project: Research

NMA HREC Reference Number: HREC/17/MonH/29
NMA SSA Reference Number: SSA/17/MonH/289
Monash Health Ref: 17-0000-082A

Status	Active
Effective start/end date	4/01/19 → 3/01/24